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Abstract
Background: More women than men have PAD with exception for the stage intermittent claudication (IC). The
purpose of this study was to evaluate differences in disease characteristics between men and women when using
current diagnostic criteria for making the diagnosis IC, defined as ABI < 0.9 and walking problems.
Study Design: Cohort study
Methods: 5040 elderly (median age 71) subjects participated in a point-prevalence study 2004. They had their ABI
measured and filled out questionnaires covering medical history, current medication, PAD symptoms and walking
ability. The prevalence of IC was 6.5% for women and 7.2% for men (P = 0.09). A subset of subjects with IC (N =
56) was followed up four years later with the same procedures. They also performed additional tests aiming to
determine all factors influencing walking ability.
Results: Men with IC had more concomitant cardiovascular disease and a more profound smoking history than
women. Women, on the other hand, reported a lower walking speed (P < 0.01) and more joint problems (P =
0.018). In the follow up cohort ABI, walking ability and amount of atherosclerosis were similar among the sexes,
but women more often reported atypical IC symptoms.
Conclusion: Sex differences in the description of IC symptoms may influence diagnosis even if objective features
of PAD are similar. This may influence accuracy of prevalence estimates and selection to treatment.
Background
Peripheral arterial disease (PAD) is common in western
countries, affecting almost 20% of elderly populations
and its prevalence differs between sexes. Findings of the
Swedish PAD Prevalence Study (SPPS) revealed that
women are more likely to suffer from PAD when diag-
nosis is based only on ankle brachial indices (ABI) but
when diagnosis relies on additional assessment of symp-
toms (ie IC) sex differences disappears [1,2].
The prevalence of IC is around 7% among elderly [1],
and considerably diminishes patients’ quality of life
(QoL) [3,4] The extent of this influence on QoL deter-
mines whether surgical intervention is indicated.
Accordingly, a correct diagnosis, accurate assessment of
disease severity and weighing the risk associated with
the procedure against the magnitude of potential symp-
tomatic improvement is essential for recommending the
best treatment option. A correct diagnosis is also essen-
tial to enable appropriate modification of cardiovascular
(CV) risk factors and to prevent CV morbidity and
death [5].
There are some reports in the literature that men and
women with IC are treated differently [6,7]. One exam-
ple is the amount of resources spent on treatment.
According to the Swedish Vascular Registry men
undergo more interventions for IC than women [8].
Another example is that women appear to seek treat-
ment when they have more advanced disease than men
[6]. It is possible that a sex difference in prevalence is
the explanation for this, but patients’ perception of their
symptoms may also contribute to these observations.
The latter is further supported by comparable data for
ischemic heart disease [9,10]. Accordingly, any occurring
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influence making the diagnosis needs to be clarified,
since it may influence epidemiologic data and selection
to treatment.
We hypothesized that there might be differences in
perception of IC symptoms, risk factor occurrence and
extent of leg artery atherosclerosis between men and
women that may influence diagnosis. The purpose of
this study was to evaluate differences in disease charac-
teristics between men and women when using current
diagnostic criteria for making the diagnosis IC.
Methods
The study consists of two parts: A) an analysis of sex
differences in risk factors among IC patients in a large
cohort of Swedish elderly habitants, and B) an in-depth
analysis of IC disease characteristics in a smaller sample
from this cohort.
The main purpose of Part A cohort was to estimate
general sex differences in perception of walking ability
in elderly with and without IC using the SPPS. Briefly,
this population based point-prevalence study was con-
ducted in four Swedish regions during 2004 and
included questionnaire results of 5080 men and women
taken from 8000 randomly selected participants aged
60-90 years. They also had their ABI measured. In this
cohort 6.8% (CI 6.5-7.1) had IC. [1]. Questionnaire data
collected included details in walking ability, self reported
concomitant diseases, medication use, and risk factor
occurrence. A detailed description of study design,
methodology and validity of SPPS has been published
previously [7]. For Part B all subjects with IC living in
one of the region (Karlstad) were invited to a follow up
study. The purpose of Part B was to elucidate any sex
differences in leg artery atherosclerosis distribution,
walking ability, perception of symptoms, as well as
detecting if any severe heart failure was contributing to
a possibly observed sex difference in walking ability
Study populations
Part A uses the following cohorts from SPPS:
Group 1. IC; All subjects with ABI < 0.9 and a posi-
tive answer in Rose questionnaire [11], (N = 333,
180 women and 153 men).
Group 2. Control group; All subjects with ABI > 0.9
and a negative answer in Rose questionnaire (N =
3313, 1734 women and 1579 men).
A subgroup from Group 1 was used for Part B:
G r o u p3 .S u b g r o u pI C ;All subjects from Group 1
living in one of the regions used 2004 (Karlstad, N =
88, 51 women and 37 men) screened for possible
enrolment in the follow-up study. Nineteen had died
in 2008 (nine of CV causes, five defined as non-CV
and for five subjects data was missing) the remaining
69 subjects were invited. Of those 81% (n = 56) of
the survivors, 35 women agreed to participate. Ten
of those subjects were assessed to a home visit
because of immobility and only answered the ques-
tionnaires and had ABI measured.
Analyses
Part A
Walking Impairment Questionnaire (WIQ) answers, ABI
values, Rose questionnaire answers, smoking habits,
medication use and concomitant diseases were analyzed
for Groups 1 and 2 using data collected 2004.
Concomitant diseases, medication and smoking use
were self-reported by the subjects. More details about
its use and analysis in presented in a previous publica-
tion from SPPS [1].
WIQ is divided in three components estimating walk-
ing distance, walking speed and stair-climbing ability
[12]. For each component subjects rank the degree of
difficulties on a scale from 0 to 4 (0 = unable, 4 = no
difficulties) and a summary score is then calculated for
each component as a percentage (% score = individual
score/4 × 100).
ABI was defined as the ratio of the lowest systolic
pressure of the two measured arteries in the ankle
divided by systolic blood pressure in the arm [13].
Part B
Collected background data consisted of the following
￿ Medical history (risk factors, co-morbidities and
medication use as in Part A),
￿ Death rate and cause of death (obtained from hos-
pital records),
￿ ABI (as in Group A).
Part B also covered additional tests to further assess
walking ability and QoL:
￿ Six-minutes walking test (6MWT) [14], which
assesses peak walking distance. It took place indoors
in a 50 m long hallway with marks every 5 m. Sub-
jects were asked to cover as many laps as possible in
6 minutes. If the subject needed to stop for any rea-
son he or she was allowed to rest but encouraged to
resume walking. The clock continued to run during
the resting period. The time to the first stop, the
cause of the stop and the total distance were
recorded.
￿ Intermittent Claudication Questionnaire (ICQ) is a
disease specific instrument for evaluation of QoL.
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Page 2 of 8It consists of 16 questions, four evaluating walking
distance and stair climbing ability. The results
obtained from these questions are presented in a
six-graded scale (from totally limited to no limitation
at all). The remaining 12 questions correlate with
the questionnaires EuroQoL and SF-36 and evaluate
daily routines, including physical activities, social
activities and physical health, and is scored in a five
graded scale [15]. Subjects’ responses to each ques-
tion are summed up and transformed to a 0 to 100
scale, where 0 (the opposite of the WIQ system) is
best possible and 100 the worst possible health state.
Examinations in this group also aimed to describe
atherosclerotic disease distribution and evaluate effects
of heart disease on walking ability:
￿ Duplex ultrasound (DUS) scanning of leg arteries
covered the arterial segments from aortic bifurcation
to the Popliteal artery below the knee.
￿ Echocardiography was performed and as an index
of left ventricular systolic function, ejection fraction
(EF) was calculated using the apical biplane Simp-
son’s method of discs [16].
D e t a i l so ft h e s em e t h o d sa n dt h e i re v a l u a t i o ni sp r o -
vided at the end of this manuscript as an appendix
(Additional file 1).
A left ventricular ejection fraction (EF) less than 50%
was considered as an index of impaired systolic
function.
Part B also included a descriptive analysis of symp-
toms using a semi-structured interview. It was con-
ducted by asking each subject eight questions with open
answering alternatives (Table 1). Questions were
designed together with an expert nurse in QoL research.
The interview took place in a quiet consulting room and
a tape recorder was used.
Ethical approval
The sub-study was approved by the Ethics committee at
Uppsala University (Dnr 2008/056). and SPPS by five
separate committees Stockholm (KI 03-538), Umeå
University (Dnr 03-459) Lunds University (Dnr832-0)
Uppsala University (Dnr 03-564) and Örebro (Dnr 374-
03). Informed consent was obtained from each
participant.
Statistics
Binary data was described using numbers and propor-
tions. For age we used sample means and standard
deviations. All other data are described by medians and
interquartile range (IQR). For ABI we used non-para-
metric statistics (both descriptive and adjusted by means
of non-parametric quartile regression on the median)
since it showed significant deviations (Shapiro-Wilks
test, p < 0.001) from the normal distribution. Within
group differences between sexes was compared using
Mann-Whitney U-test. Presented correlations are Spear-
man rank correlations tested for deviations from the
null hypothesis using an asymptotic test. For comparing
proportions between sexes we used Fisher’s exact test.
All analyses were performed with STATA/IC for Win-
dows version 10 (STATA Corp LP. College Station,
Texas). P-values below level 0.05 were considered to be
statistically significant.
Results
Part A
Baseline data for Group 1(IC patients) (n = 333) and
Group 2 (control subjects) (n = 3322) are presented in
Table 2. Group 1 subjects were older compared to
Group 2 (p < 0.001). Men were more likely to have
suffered a stroke in both groups (Group 1 p < 0.001;
Group 2 p = 0.007). In Group 1 men were more likely
to suffer from DM than women (p = 0.047), and in
both groups men were more likely to have CAD than
w o m e n( G r o u p1m e np<0 . 0 0 1 ;G r o u p2p<0 . 0 0 1 ) .
Smoking habits, while more common in Group 1 com-
pared to Group 2 (62.5% vs 50.8%, p < 0.001), revealed
similar patterns from a sex perspective in both groups.
There was however an increased likelihood of a smok-
ing history in men (Group 1 p < 0.001; Group 2 p <
0.001).
Walking distance (p < 0.001) and speed (p < 0.001) as
well as stair climbing ability (p < 0.001) were signifi-
cantly worse for women as compared to men in Group
1. While women in Group 2, experienced more pro-
blems with lower walking speed (p = 0.013), joint pro-
blems (p = 0.018) and heart palpitations (p = 0.002).
Part B
W o m e na n dm e ni nG r o u p3d e c r e a s e dA B Iv a l u e s
between 2004 and 2008 to a similar extent, from 0.67
(SD 0.13) to 0.44 (0.39) in men and 0.69 (0.15) to 0.44
(0.40) in women (p > 0.001). Walking ability as assessed
by WIQ also changed during the four years in all
Table 1 Semi-structured Interview Questions
1. Do you have any pain while walking?
2. If, can you describe the symptoms
3. In what way does the symptom influence you?
4. Have you searched medical attention for your problem?
5. How often do you leave your home?
6. What kind of activities do you do?
7. Are you independent in activity in daily life?
8. If you are dependent on help, who will help you?
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78.6(SD 19.8) to 66.2 (30.6), distance from 54.2 (36.4) to
35.4 (30.6) and for speed from 34.9 (22.9) to 20.1 (20.2).
The corresponding figures for women were for pain, dis-
tance- and speed respectively; 65.7 (33.8) to 76.4 (33.2),
47.3 (35.8) to 49.3 (41.7) and 31.5 (25.8) to 21.8 (14.6).
Walking distances were similar between the sexes,
with pain free distance of 111 m (SD 132) for men and
137 m (SD 160) for women (P = 0.58), and absolute dis-
tances of 288 m (SD 138) for men and 296 m (SD 160)
for women (P = 0.19).
ICQ data showed that women spent more time think-
ing about leg pain (p = 0.045) and although not statisti-
c a l l ys i g n i f i c a n ts h o w e dt h a tm e nw e r em o r el i k e l yt o
report severe leg pain, (p = 0.067) (Table 3). There was
no significant difference in the presence of vessel steno-
sis identified on DUS between men and women at the
level of the Iliac artery (p = 0.373), Superficial Femoral
artery (p = 0.513), and or Politeal artery (p = 1.0) (Fig-
ure 1). For the heart. left ventricular systolic dysfunction
tended to be more common in men, with a reduced
ejection fraction in 41% of men compared to 15% of
Table 2 Baseline characteristics
Group 1(IC) Group 2 (Control) Group 3(Follow-up IC)
Men
(N = 153)
(46.0%)
Women
(N = 180)
(54.0%)
Men
(N = 1579)
(47.7%)
Women
(N = 1734)
(52.3%)
Men
(N = 37)
(42.1%)
Women
(N = 51)
(58.0%)
Age
Mean (Std.dev.)
76.3(8.1) 77.0(7.8) 69.9(7.3) 70.6(7.6) 78.7(8.12) 77.5(7.96)
ABI
Median (IQR)
0.72(0.19) 0.71(0.29) 1.07(0.14) 1.00(0.10) 0.69 (0.21) 0.71 (0.29)
(p-value)*** (0.438) (< .001) (0.74)
Concomittant diseases
N (%)
Diabetes n = 3646 42 (27.5) 32 (17.8) 125 (7.9) 119 (6.9) 9 (25.0) 4 (7.7)
(p-value)** (0.047) (.258) (0.033)
Hypertension
n = 3646
86 (56.2) 97 (53.9) 494(31.3) 592(34.1) 19 (52.8) 31 (59.6)
(p-value)** (0.740) (0.082) (0.662)
Stroke
n = 3646
38 (24.8) 12 (6.7) 103 (6.5) 76 (4.4) 9 (25.0) 3 (5.8)
(p-value)** (< 0.001) (0.007) (0.013)
CAD#
n = 3646
26 (17.0) 8 (4.4) 271 (17.2) 222 (12.8) 6 (16.7) 3 (5.8)
(p-value)** (< 0.001) (< 0.001) (0.151)
Medication use
N (%)
Anti-platelet
therapy, n = 2380
134 (99.3) 151 (96.8) 868 (91.5) 1066 (93.5) 34 (100) 47 (97.9)
(p-value)** (0.221) (0.079) (1.00)
Lipidlowering therapy, n = 2380 53 (39.3) 45 (28.9) 238 (25.1) 214 (18.8) 12 (35.3) 13 (27.1)
(p-value)** (0.064) (< 0.001) (0.472)
ACE-inhib. Betablockers n = 2380 73 (54.7) 82 (52.6) 420 (44.3) 397 (34.8) 25 (73.5) 28 (58.3)
(p-value)** (0.815) (< 0.001) (0.170)
WIQ subscales
WIQ distance* 44.6 36.1 100.0 100.0 34.5 40.3
(p-value)*** (0.121) (0.833)
WIQ speed* 26.1 21.7 89.1 68.5 20.7 23.9
(p-value)*** (0.013) (< 0.001) (0.860)
WIQ stairs* 43.8 41.7 100.0 87.5 41.7 37.5
(p-value)*** (0.13) (< 0.001) (0.937)
Smoking ever
N (%)
Yes 119 (77.8) 89 (49.4) 968 (61.3) 716 (41.3) 26 (72.2) 29 (55.8)
(p-value) *** (< 0.001) (< 0.001) (0.179)
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observed between EF and 6MWT distances (rho = 0.21,
p = 0.19).
Men presented classic IC symptoms (i.e. pain and
cramp) in the interview (Table 1 question 2) more fre-
q u e n t l yt h a nw o m e nw h oi nt u r nm o r eo f t e nd e s c r i b e d
symptoms as tiredness, unsteadiness, numbness and sor-
row (75% vs. 41% p = 0.086). A higher proportion of
men regularly left their homes (25% vs 7%, p = 0.097),
and men sought medical care three times as often as
women (67% vs 19% p = 0.011). Sixty-three percent of
the interviewed men (and 52% of women) were
dependent on aid and a majority of them was supported
by their spouses (89%), whereas women used profes-
sional assistance (57%) or their children (36%).
Discussion
This study presents some new findings that may be of
importance when diagnosing and evaluating IC. First,
men are more likely to have suffered from a CV disease
than women and women tend to perceive a reduced
walking ability more often than men do regardless if
they are diagnosed as suffering from IC or not. Second,
women and men diagnosed with IC appear to have simi-
lar extent and type of disease when objective measures
are employed. Third, when these IC patients are inter-
viewed about their problems, women more often
describe a reduced need of walking ability, or habit of
walking compared to men.
Men have a greater CV disease burden than women in
the present study, which is a common finding through-
out the current published literature. It is valid also after
adjustment for age [17,18] and supports the notion that
IC should be more common in men [2,19-21]. IC was
indeed more common in men in the few early IC preva-
lence studies that enrolled women [20,22], but more
recent publications report a sex neutral prevalence
[23-25]. The reasons for a diverging pattern in preva-
lence for IC compared to other PAD stages could be
explained by most epidemiological studies use of only
questionnaire as diagnostic tool for IC diagnosis [26]. In
Part A of this study that combined questionnaires with
ABI for IC diagnosis it appears that the IC patients are
correctly diagnosed. This is supported by Duplex find-
ings of leg artery in the follow up study. Accordingly,
falsely diagnosed IC patients in this study were not
identified.
Table 3 Responses of the Intermittent Claudication Questoinnaire in Group 3 (Subgroup IC)
Score Median and Quartiles (Q) Men Women P-value*
Q1 Median Q1 Median Q3
Severity of leg pain 3 3 4 0.75 3 4 0.067
Pain limiting using bus, train or tube 0 0 2 0 0 2 0.992
Pain limiting climbing several flights of stairs 0 0 0 0 1 2 0.346
Pain limiting climbing one flight of stairs 2 3 3 1 2 4 0.319
Pain limiting walking more than 1 mile 1 1 2 0 1 3 0.551
Pain limiting walking 100 yards 2.5 3 4 1 4 4 0.934
Pain limiting leaving house 0 1 2 0 0 2 0.827
Pain when stopped walking 0 1 3 0 1 3 0.972
Time spent thinking about leg pain 0 1 3 0 2 3 0.045
Felt downhearted and low because of pain 2 3 3 1 2 3 0.075
Time spent worrying that pain will worsen 0 1 2.5 0 1 3 0.640
Interference with normal work 1 2 2.5 0 1 2 0.162
(0 = best possible health state, 4 = worst possible health state)
* P-values comparing differences between sexes using Mann-Whitney’s U-test.
Figure 1 Frequencies of stenosis and/or occlusions in lower
limb arteries imaged by Duplex Ultrasound separated by sex
in subgroup IC (with 95% CI) (Iliaca corresponds to the Common
and External Iliac Artery, SFA to the Femoral Superficial Artery, PoP
AK and BK to the Popliteal Artery above and below knee).
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ABI criteria appears to have a good sensitivity for diag-
nosing IC, this combination may still fail to diagnose
some patients with IC. There are a few indications that
this may have occurred for women in the present study.
Men but not women in the subgroup IC had deterio-
rated WIQ scores over time. This can be explained if
men had correctly diagnosed IC in 2004 that then dete-
riorated over time at a pace that can be expected for IC
patients, while some women had a walking problems
caused by a non-vascular disease that doesn’t deteriorate
at the same rate. One example of such could be spinal
s t e n o s i s[ 2 7 ] .I ti sa l s or eported that women with IC
ambulate slower than men, which can influence diagno-
sis [28]. In our study, on the other hand, there was an
identical reduction in ABI and walking distances over
time in both sexes with IC. Another possibility is that
WIQ is not an accurate instrument for assessing walking
ability in women. WIQ is validated against treadmill
walking but atypical leg symptoms are not well covered
by this instrument [29].
Interestingly, women from the Group 2 (control)
scored lower in all WIQ domains, and thus experienced
more leg problems, despite men reporting more conco-
mitant CV disease. In general, women’sw a l k i n gp r o -
blems appear to be more imprecise and distorted by
bodily pain, stiffness in joints, discomfort in the chest
and general weakness. It is likely that such general per-
ception will make IC symptoms more indistinct in
women, and this may influence prevalence data using
Rose Questionnaire. Whether more recently developed
instruments such as the Edinburgh Claudication Ques-
tionnaire or similar ones will solve this potential pro-
blem of under-diagnosing IC in women is unknown
[11,30]. Few studies have addressed the problem of aty-
pical IC symptoms in PAD but it is well-documented
for coronary heart disease [31-33].
Diagnosis of IC also depends on the degree of walking
impairment but all subjects with IC needs to be diag-
nosed to enable CV risk reduction measures, including
very mild IC, that do not requires symptomatic treat-
ment. Whether women and men with IC have different
walking abilities is unknown. Gardner et al. reported
that men and women with IC had similar 6MWT walk-
ing distances, but in a treadmill test women walked
shorter distances [34]. The explanation given for this
observation was a reduced pulmonary function that
influenced walking ability in women. McDermott also
found a greater functional impairment among women
with IC compared to men. The reason given was dimin-
ished leg muscle strength in women [27]. Our data
reports a similar disease distribution between the sexes
on DUS and a possibly better heart function in women,
opposing the notion that women have less severe PAD.
Overall it is difficult to find clear support for an appro-
priate sex difference in resource allocation for sympto-
matic treatment of IC.
The severity of walking impairment is only one com-
ponent of the clinical entity IC that is important to con-
sider when deciding whether a patient should be offered
symptomatic treatment. A short walking distance might
be a severe disability for one person but perfectly accep-
table for another. While the only sex-differences in ICQ
scores concerned leg pain (where men experienced
more problems), women reported lower physical func-
tion and ability to perform daily life activities. These
results are consistent with a previous data where
women perceived a lower physical function, mood state
and greater bodily pain than men despite similar disease
severity [31,35]. Accordingly, there appears to be a clear
sex difference in perception of the limitation caused by
IC. This difference may be a consequence of divergent
walking habits and needs. In the interviews performed
in this study it was obvious that men were more physi-
cally active than women and that women did not leave
their houses as often and were more dependent of sup-
port [24,35,36]. Despite the fact that a compromised
walking ability is the main feature of IC disease, only
34% of the subjects in Group 3, who reported that they
could walk slightly more than 100 m, had been subject
to medical care for their disease, and more men had
received treatment. If women tend to ignore the severity
of their IC symptoms they do not look for medical care.
Some limitations of this study are apparent. Few sta-
tistically significant differences between the sexes were
observed in Part B, which could be caused by the small
cohort size and it is possible that larger and more signif-
icant differences between the sexes would have been
identified if a larger cohort had been recruited. Another
potential issue is the ability to generalize our results to
the entire IC population. Group 3 was an acceptable
approximation of the demographics of Group 2 (Table
4), but while criteria used to identify this cohort are
applicable for epidemiology studies but not entirely con-
sistent with day to day clinical praxis as for example self
reported questionnaires.
Conclusion
Sex differences in the description of IC symptoms may
influence diagnosis even if objective features of PAD are
similar. Men claim to suffer from more pain while
women have a greater walking impairment and describe
symptoms more atypical. IC prevalence and its conse-
quences may be underestimated in women and this
need to be considered in epidemiological studies, clinical
trials and as indication for revascularization.
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cal symptoms of IC among women should be viewed as
having a similar consequence on exercise performance
as that of classical IC or similar.
Additional material
Additional file 1: Methodology and evaluation of Duplex ultrasound
and Echocardiography. An appendix with detailed description of
methodology of preformed Duplex ultrasound of leg arteries and
Echocardiography
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